Last reviewed · How we verify
TECHNETIUM TC 99M RED BLOOD CELLS — Competitive Intelligence Brief
marketed
Live · refreshed every 30 min
Target snapshot
TECHNETIUM TC 99M RED BLOOD CELLS (TECHNETIUM TC 99M RED BLOOD CELLS).
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| TECHNETIUM TC 99M RED BLOOD CELLS TARGET | TECHNETIUM TC 99M RED BLOOD CELLS | marketed | 1991-01-01 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- TECHNETIUM TC 99M RED BLOOD CELLS CI watch — RSS
- TECHNETIUM TC 99M RED BLOOD CELLS CI watch — Atom
- TECHNETIUM TC 99M RED BLOOD CELLS CI watch — JSON
- TECHNETIUM TC 99M RED BLOOD CELLS alone — RSS
Cite this brief
Drug Landscape (2026). TECHNETIUM TC 99M RED BLOOD CELLS — Competitive Intelligence Brief. https://druglandscape.com/ci/technetium-tc-99m-red-blood-cells. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab